Literature DB >> 33389956

Present and Future of Digital Health in Diabetes and Metabolic Disease.

Sang Youl Rhee1,2, Chiweon Kim3, Dong Wook Shin4,5, Steven R Steinhubl2.   

Abstract

The use of information and communication technology (ICT) in medical and healthcare services goes beyond everyday life. Expectations of a new medical environment, not previously experienced by ICT, exist in the near future. In particular, chronic metabolic diseases such as diabetes and obesity, have a high prevalence and high social and economic burden. In addition, the continuous evaluation and monitoring of daily life is important for effective treatment and management. Therefore, the wide use of ICTbased digital health systems is required for the treatment and management of these diseases. In this article, we compiled a variety of digital health technologies introduced to date in the field of diabetes and metabolic diseases.

Entities:  

Keywords:  Diabetes mellitus; Education; Mobile applications; Nutritional sciences; Obesity; Prediabetic state; Prevention and control

Year:  2020        PMID: 33389956     DOI: 10.4093/dmj.2020.0088

Source DB:  PubMed          Journal:  Diabetes Metab J        ISSN: 2233-6079            Impact factor:   5.376


  5 in total

1.  Qatar Diabetes Mobile Application Trial (QDMAT): an open-label randomised controlled trial to examine the impact of using a mobile application to improve diabetes care in type 2 diabetes mellitus-a study protocol.

Authors:  Noor Suleiman; Meis Alkasem; Zaina Al Amer; Obada Salameh; Noora Al-Thani; Mohammad Khair Hamad; Khaled Baagar; Ibrahem Abdalhakam; Manal Othman; Ragae Dughmosh; Dabia Al-Mohanadi; Ali Al Sanousi; Mohammed Bashir; Odette Chagoury; Shahrad Taheri; Abdul-Badi Abou-Samra
Journal:  Trials       Date:  2022-06-16       Impact factor: 2.728

2.  Prevalence of Hyperuricemia Among Chinese Adults: Findings From Two Nationally Representative Cross-Sectional Surveys in 2015-16 and 2018-19.

Authors:  Mei Zhang; Xiaoxia Zhu; Jing Wu; Zhengjing Huang; Zhenping Zhao; Xiao Zhang; Yu Xue; Weiguo Wan; Chun Li; Wenrong Zhang; Linhong Wang; Maigeng Zhou; Hejian Zou; Limin Wang
Journal:  Front Immunol       Date:  2022-02-07       Impact factor: 7.561

3.  Blood Pressure Monitoring as a Digital Health Tool for Improving Diabetes Clinical Outcomes: Retrospective Real-world Study.

Authors:  Yifat Fundoiano-Hershcovitz; Dror Bacher; Marilyn D Ritholz; David L Horwitz; Omar Manejwala; Pavel Goldstein
Journal:  J Med Internet Res       Date:  2022-02-08       Impact factor: 5.428

Review 4.  Innovations in Cardio-oncology Resulting from the COVID-19 Pandemic.

Authors:  Lavanya Kondapalli; Garima Arora; Riem Hawi; Efstathia Andrikopoulou; Courtney Estes; Nirav Patel; Carrie G Lenneman
Journal:  Curr Treat Options Oncol       Date:  2022-08-15

5.  Efficacy of Personalized Diabetes Self-care Using an Electronic Medical Record-Integrated Mobile App in Patients With Type 2 Diabetes: 6-Month Randomized Controlled Trial.

Authors:  Eun Young Lee; Seon-Ah Cha; Jae-Seung Yun; Sun-Young Lim; Jin-Hee Lee; Yu-Bae Ahn; Kun-Ho Yoon; Min Kyung Hyun; Seung-Hyun Ko
Journal:  J Med Internet Res       Date:  2022-07-28       Impact factor: 7.076

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.